11/ References
@integralanswers
Curious Healthcare Professional with a passion for dispelling intentional disinformation especially within the medicine and science spheres. Networking with Pro-Science & Evidenced Based Medicine. Amateur Photographer #WeCare, #Photography
11/ References
10/ Fair takeaway: Seheult’s framework is strongest on (1) circadian light, (2) plausible PBM mechanisms, (3) early human signals in select contexts. What’s needed next: replication, standardized dosing, and long-term endpoints.
9/ Practical nuance from “sun rules”: glass reliably blocks UVB (so indoor sun won’t do much for vitamin D). But IR/NIR transmission varies with window type/coatings—so one universal % claim won’t fit all situations.
8/ Important limit: these studies may show specific measured endpoint changes—they don’t prove broad claims (immunity, longevity, chronic disease prevention). That leap requires larger, long-duration human trials with hard outcomes.
8/ Important limit: these studies may show specific measured endpoint changes—they don’t prove broad claims (immunity, longevity, chronic disease prevention). That leap requires larger, long-duration human trials with hard outcomes.
7/ Systemic-effect claim: newer work suggests longer wavelengths can penetrate tissue and may produce distal effects. Some studies report measurable endpoint changes even when eyes are shielded—suggesting systemic signaling is possible.
6/ Clinical trials exist in specific contexts. Example: a randomized, triple-blind, sham-controlled ICU trial reported shorter ICU stay + improved mobility/strength with PBM. Promising—still needs replication across centers/protocols.
5/ A concrete human finding: 670-nm red light (15 min) reduced the glucose rise after a glucose challenge in healthy adults. Interesting acute physiology—NOT proof it treats diabetes or improves long-term metabolic outcomes yet.
4/ Key caution: mechanism ≠ broad clinical promise. PBM effects depend on wavelength, dose, timing, target tissue, and baseline health. “Works in cells” doesn’t guarantee “works for everyone, outdoors, daily” without outcome trials.
4/ Key caution: mechanism ≠ broad clinical promise. PBM effects depend on wavelength, dose, timing, target tissue, and baseline health. “Works in cells” doesn’t guarantee “works for everyone, outdoors, daily” without outcome trials.
3/ Mechanism: PBM biology is plausible and well described—red/NIR photons interact with mitochondrial chromophores (often cytochrome-c oxidase), shifting NO/ETC signaling → ↑ATP and downstream redox/inflammation signaling.
2/ Strongest support: morning outdoor light to the eyes helps set circadian phase and can improve sleep timing + next-day alertness/mood in many settings. This is the most evidence-dense part of the “sunlight” story.
1/ Dr. Roger Seheult (MedCram) argues that natural light + red/near-infrared (NIR) exposure can benefit health—via circadian timing + mitochondrial “photobiomodulation” (PBM). Here’s what evidence supports vs what’s still early. 🧵
1/ Dr. Roger Seheult (MedCram) argues that natural light + red/near-infrared (NIR) exposure can benefit health—via circadian timing + mitochondrial “photobiomodulation” (PBM). Here’s what evidence supports vs what’s still early. 🧵
Dr. Roger Seheult argues sunlight matters beyond vitamin D—circadian timing + red/near-IR photobiomodulation. This thread separates strong evidence from early signals, using peer-reviewed studies. 🧵
Heads up for Supporters on Dr. Peter Hotez who have an account on that other platform.
12/ • UNAIDS — HIV treatment disruption impacts
• World Food Programme (WFP) — food aid loss & famine risk
11/ Estimates & impacts cited in this thread draw from:
• The Lancet — projected excess mortality from USAID defunding
• Center for Global Development (CGD) — updated mortality modeling
10/ The cost of defunding USAID is now measurable in graves. Restoring funding doesn’t just rebuild programs—it prevents deaths that are already underway. This is not abstract. It’s happening now.
9/ These deaths are not caused by lack of knowledge or tools. They result from policy choices that interrupt proven interventions: food aid, vaccines, HIV treatment, TB control, malaria prevention.
8/ Looking forward: Peer-reviewed projections still estimate >14 million preventable deaths by 2030 if USAID funding is not restored—~4.5 million of them children under five.
7/ Health system collapse multiplies harm. When clinics close or staff are unpaid, deaths rise not only from famine and infection—but from childbirth complications, untreated injuries, and chronic disease.
6/ Food aid disruptions are directly linked to mortality. Destroyed or stalled emergency rations remove the last buffer between food insecurity and famine, particularly in conflict zones and drought-affected regions.
5/ HIV programs have been especially vulnerable. Interruptions in antiretroviral supply chains increase viral rebound, transmission, drug resistance, and mortality—effects that compound rapidly once treatment stops.
4/ Children are bearing the brunt. Analyses indicate over half of excess deaths are among children under 5, driven by malnutrition, vaccine gaps, diarrhea, pneumonia, malaria, and measles.
3/ Recent updates suggest 500,000–1.6 million additional deaths annually may already be occurring due to aid disruption—depending on how sharply funding and delivery have declined across regions.
2/ Independent modeling groups estimate that reduced U.S. foreign aid is now contributing to hundreds of thousands of excess deaths per year, largely from preventable causes: hunger, infections, and interrupted care.
1/ 🧵 UPDATE: The human cost of defunding USAID is no longer theoretical. New analyses show the impacts are already being measured in lives lost, not just programs paused.